Day: May 29, 2026

Sermorelin is increasingly marketed for midlife fatigue, body composition, and anti-aging. Here’s what the evidence actually supports, the fatigue workup we’d do first, and the questions to ask before considering a peptide prescription.

The compounded semaglutide market has narrowed since the FDA removed the drug from its shortage list. Here’s what changed, the questions to ask before starting or continuing, and how we’d think about the decision as clinicians in 2026.